Cardio-Ankle Vascular Index and Ankle Pulse Wave Velocity as a Marker of Arterial Fibrosis in Kidney Failure Treated by Hemodialysis

Atsuhiro Ichihara, Norimasa Yamashita, Tomoko Takemitsu, Yuki Kaneshiro, Mariyo Sakoda, Asako Kurauchi-Mito, Hiroshi Itoh

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: Patients with kidney failure treated with hemodialysis have a high incidence of cardiovascular diseases caused by accelerated arteriosclerosis. However, accurate evaluation of the extent of arteriosclerosis is difficult. This study sought to compare the strength of predictions of arterial fibrosis by using a new parameter, the cardio-ankle vascular index (CAVI), versus pulse wave velocity (PWV) in patients with kidney failure treated with hemodialysis. Study Design: Diagnostic test study. Setting & Participants: 103 patients with kidney failure undergoing surgical construction of an arteriovenous access for hemodialysis therapy. Index Test: CAVI and PWV. Reference Test: Arterial fibrosis, evaluated by using Masson trichrome stain on part of the brachial artery obtained during surgery, expressed as percentage of fibrosis of the layer of vascular smooth muscle cells. Results: Median percentage of arterial stiffness was 52.85%. Mean PWV and CAVI were 18.3 ± 5.6 (SD) m/s and 9.9 ± 2.6, respectively. Multivariate regression analysis showed that arterial fibrosis was significantly associated with older age (0.247%/y; 95% confidence interval, 0.013 to 0.482) and CAVI (6.117%/unit; 95% confidence interval, 4.764 to 4.740), but not with systolic blood pressure (0.039%/mm Hg; 95% confidence interval, -0.076 to 0.153) or PWV (-0.044%/m/s; 95% confidence interval, -0.646 to 0.558). The area under the receiver operating characteristic curve to predict greater than median percentage of arterial stiffness was 0.892 for CAVI and 0.779 for PWV (P = 0.006). Limitation: It is unclear whether arterial fibrosis of the brachial artery evaluated by using CAVI is applicable for arteriosclerosis of other arterial districts, and clinical outcomes were not evaluated in this study. Conclusion: CAVI reflects the histological arterial fibrosis of hemodialysis patients and is a useful clinical marker for evaluating arterial stiffness in these patients.

Original languageEnglish
Pages (from-to)947-955
Number of pages9
JournalAmerican Journal of Kidney Diseases
Volume52
Issue number5
DOIs
Publication statusPublished - 2008 Nov

Fingerprint

Pulse Wave Analysis
Ankle
Renal Insufficiency
Blood Vessels
Renal Dialysis
Fibrosis
Vascular Stiffness
Arteriosclerosis
Confidence Intervals
Brachial Artery
Blood Pressure
Vascular Smooth Muscle
Routine Diagnostic Tests
ROC Curve
Smooth Muscle Myocytes
Cardiovascular Diseases
Multivariate Analysis
Biomarkers
Regression Analysis
Incidence

Keywords

  • Arteriosclerosis
  • blood pressure
  • diabetes
  • lipid
  • Masson trichrome

ASJC Scopus subject areas

  • Nephrology

Cite this

Cardio-Ankle Vascular Index and Ankle Pulse Wave Velocity as a Marker of Arterial Fibrosis in Kidney Failure Treated by Hemodialysis. / Ichihara, Atsuhiro; Yamashita, Norimasa; Takemitsu, Tomoko; Kaneshiro, Yuki; Sakoda, Mariyo; Kurauchi-Mito, Asako; Itoh, Hiroshi.

In: American Journal of Kidney Diseases, Vol. 52, No. 5, 11.2008, p. 947-955.

Research output: Contribution to journalArticle

Ichihara, Atsuhiro ; Yamashita, Norimasa ; Takemitsu, Tomoko ; Kaneshiro, Yuki ; Sakoda, Mariyo ; Kurauchi-Mito, Asako ; Itoh, Hiroshi. / Cardio-Ankle Vascular Index and Ankle Pulse Wave Velocity as a Marker of Arterial Fibrosis in Kidney Failure Treated by Hemodialysis. In: American Journal of Kidney Diseases. 2008 ; Vol. 52, No. 5. pp. 947-955.
@article{9e30953ab7ca4662a3a3386dfa397bb4,
title = "Cardio-Ankle Vascular Index and Ankle Pulse Wave Velocity as a Marker of Arterial Fibrosis in Kidney Failure Treated by Hemodialysis",
abstract = "Background: Patients with kidney failure treated with hemodialysis have a high incidence of cardiovascular diseases caused by accelerated arteriosclerosis. However, accurate evaluation of the extent of arteriosclerosis is difficult. This study sought to compare the strength of predictions of arterial fibrosis by using a new parameter, the cardio-ankle vascular index (CAVI), versus pulse wave velocity (PWV) in patients with kidney failure treated with hemodialysis. Study Design: Diagnostic test study. Setting & Participants: 103 patients with kidney failure undergoing surgical construction of an arteriovenous access for hemodialysis therapy. Index Test: CAVI and PWV. Reference Test: Arterial fibrosis, evaluated by using Masson trichrome stain on part of the brachial artery obtained during surgery, expressed as percentage of fibrosis of the layer of vascular smooth muscle cells. Results: Median percentage of arterial stiffness was 52.85{\%}. Mean PWV and CAVI were 18.3 ± 5.6 (SD) m/s and 9.9 ± 2.6, respectively. Multivariate regression analysis showed that arterial fibrosis was significantly associated with older age (0.247{\%}/y; 95{\%} confidence interval, 0.013 to 0.482) and CAVI (6.117{\%}/unit; 95{\%} confidence interval, 4.764 to 4.740), but not with systolic blood pressure (0.039{\%}/mm Hg; 95{\%} confidence interval, -0.076 to 0.153) or PWV (-0.044{\%}/m/s; 95{\%} confidence interval, -0.646 to 0.558). The area under the receiver operating characteristic curve to predict greater than median percentage of arterial stiffness was 0.892 for CAVI and 0.779 for PWV (P = 0.006). Limitation: It is unclear whether arterial fibrosis of the brachial artery evaluated by using CAVI is applicable for arteriosclerosis of other arterial districts, and clinical outcomes were not evaluated in this study. Conclusion: CAVI reflects the histological arterial fibrosis of hemodialysis patients and is a useful clinical marker for evaluating arterial stiffness in these patients.",
keywords = "Arteriosclerosis, blood pressure, diabetes, lipid, Masson trichrome",
author = "Atsuhiro Ichihara and Norimasa Yamashita and Tomoko Takemitsu and Yuki Kaneshiro and Mariyo Sakoda and Asako Kurauchi-Mito and Hiroshi Itoh",
year = "2008",
month = "11",
doi = "10.1053/j.ajkd.2008.06.007",
language = "English",
volume = "52",
pages = "947--955",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Cardio-Ankle Vascular Index and Ankle Pulse Wave Velocity as a Marker of Arterial Fibrosis in Kidney Failure Treated by Hemodialysis

AU - Ichihara, Atsuhiro

AU - Yamashita, Norimasa

AU - Takemitsu, Tomoko

AU - Kaneshiro, Yuki

AU - Sakoda, Mariyo

AU - Kurauchi-Mito, Asako

AU - Itoh, Hiroshi

PY - 2008/11

Y1 - 2008/11

N2 - Background: Patients with kidney failure treated with hemodialysis have a high incidence of cardiovascular diseases caused by accelerated arteriosclerosis. However, accurate evaluation of the extent of arteriosclerosis is difficult. This study sought to compare the strength of predictions of arterial fibrosis by using a new parameter, the cardio-ankle vascular index (CAVI), versus pulse wave velocity (PWV) in patients with kidney failure treated with hemodialysis. Study Design: Diagnostic test study. Setting & Participants: 103 patients with kidney failure undergoing surgical construction of an arteriovenous access for hemodialysis therapy. Index Test: CAVI and PWV. Reference Test: Arterial fibrosis, evaluated by using Masson trichrome stain on part of the brachial artery obtained during surgery, expressed as percentage of fibrosis of the layer of vascular smooth muscle cells. Results: Median percentage of arterial stiffness was 52.85%. Mean PWV and CAVI were 18.3 ± 5.6 (SD) m/s and 9.9 ± 2.6, respectively. Multivariate regression analysis showed that arterial fibrosis was significantly associated with older age (0.247%/y; 95% confidence interval, 0.013 to 0.482) and CAVI (6.117%/unit; 95% confidence interval, 4.764 to 4.740), but not with systolic blood pressure (0.039%/mm Hg; 95% confidence interval, -0.076 to 0.153) or PWV (-0.044%/m/s; 95% confidence interval, -0.646 to 0.558). The area under the receiver operating characteristic curve to predict greater than median percentage of arterial stiffness was 0.892 for CAVI and 0.779 for PWV (P = 0.006). Limitation: It is unclear whether arterial fibrosis of the brachial artery evaluated by using CAVI is applicable for arteriosclerosis of other arterial districts, and clinical outcomes were not evaluated in this study. Conclusion: CAVI reflects the histological arterial fibrosis of hemodialysis patients and is a useful clinical marker for evaluating arterial stiffness in these patients.

AB - Background: Patients with kidney failure treated with hemodialysis have a high incidence of cardiovascular diseases caused by accelerated arteriosclerosis. However, accurate evaluation of the extent of arteriosclerosis is difficult. This study sought to compare the strength of predictions of arterial fibrosis by using a new parameter, the cardio-ankle vascular index (CAVI), versus pulse wave velocity (PWV) in patients with kidney failure treated with hemodialysis. Study Design: Diagnostic test study. Setting & Participants: 103 patients with kidney failure undergoing surgical construction of an arteriovenous access for hemodialysis therapy. Index Test: CAVI and PWV. Reference Test: Arterial fibrosis, evaluated by using Masson trichrome stain on part of the brachial artery obtained during surgery, expressed as percentage of fibrosis of the layer of vascular smooth muscle cells. Results: Median percentage of arterial stiffness was 52.85%. Mean PWV and CAVI were 18.3 ± 5.6 (SD) m/s and 9.9 ± 2.6, respectively. Multivariate regression analysis showed that arterial fibrosis was significantly associated with older age (0.247%/y; 95% confidence interval, 0.013 to 0.482) and CAVI (6.117%/unit; 95% confidence interval, 4.764 to 4.740), but not with systolic blood pressure (0.039%/mm Hg; 95% confidence interval, -0.076 to 0.153) or PWV (-0.044%/m/s; 95% confidence interval, -0.646 to 0.558). The area under the receiver operating characteristic curve to predict greater than median percentage of arterial stiffness was 0.892 for CAVI and 0.779 for PWV (P = 0.006). Limitation: It is unclear whether arterial fibrosis of the brachial artery evaluated by using CAVI is applicable for arteriosclerosis of other arterial districts, and clinical outcomes were not evaluated in this study. Conclusion: CAVI reflects the histological arterial fibrosis of hemodialysis patients and is a useful clinical marker for evaluating arterial stiffness in these patients.

KW - Arteriosclerosis

KW - blood pressure

KW - diabetes

KW - lipid

KW - Masson trichrome

UR - http://www.scopus.com/inward/record.url?scp=54149110158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54149110158&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2008.06.007

DO - 10.1053/j.ajkd.2008.06.007

M3 - Article

C2 - 18760518

AN - SCOPUS:54149110158

VL - 52

SP - 947

EP - 955

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5

ER -